Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB10300 | Human papillomavirus type 11 L1 capsid protein antigen | 3 | Completed | 1 |
| DB10301 | Human papillomavirus type 16 L1 capsid protein antigen | 3 | Completed | 1 |
| DB10302 | Human papillomavirus type 18 L1 capsid protein antigen | 3 | Completed | 1 |
| DB10299 | Human papillomavirus type 6 L1 capsid protein antigen | 3 | Completed | 1 |